Mirati Therapeutics Patents – Insights & Stats

Mirati Therapeutics has a total of 896 patents globally, out of which 318 have been granted. Of these 896 patents, more than 44% patents are active. The United States of America is where Mirati Therapeutics has filed the maximum number of patents, followed by Europe and Australia. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Mirati Therapeutics.

Mirati Therapeutics was founded in 1995. Mirati therapies is a focused oncology firm developing a pipeline of therapies for narrowly specified patient populations. In order to create potentially game-changing medicines with expedited development trajectories, the Mirati team is following a plan validated by their earlier work.

Do read about some of the most popular patents of Mirati Therapeutics which have been covered by us in this article and also you can find Mirati Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Mirati Therapeutics patent portfolio.

How many patents do the Founder and CEO of Mirati Therapeutics have?

The Founder and CEO Charles Baum have 1 patent.

How many patents does Mirati Therapeutics have?

Mirati Therapeutics has a total of 896 patents globally. These patents belong to 156 unique patent families. Out of 896 patents, 398 patents are active.

How Many Patents did Mirati Therapeutics File Every Year?

Mirati Therapeutics Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantMirati Therapeutics Applications FiledMirati Therapeutics Patents Granted
2023816
20225525
20214415
2020917
2019682
2018324
20171417
20161422
2015632
2014734
20131439
20122517
20115320

How many Mirati Therapeutics patents are Alive/Dead?

Worldwide Patents

Mirati Therapeutics Patent Portfolio

How Many Patents did Mirati Therapeutics File in Different Countries?

Mirati Therapeutics Worldwide Patent Filing

Countries in which Mirati Therapeutics Filed Patents

CountryPatent
United States Of America126
Europe76
Australia58
Canada44
Japan42
Korea (South)38
Hong Kong (S.A.R.)35
Mexico31
Taiwan26
China26
India25
Germany24
Austria21
Israel20
South Africa19
Brazil19
Spain17
Singapore16
New Zealand14
Argentina14
Denmark8
Malaysia7
Russia7
Colombia7
Portugal6
Philippines6
Viet Nam6
Indonesia5
Africa5
Poland4
Chile4
Norway4
Ukraine3
Saudi Arabia3
Italy3
Eurasia2
Slovenia2
Pakistan2
United Kingdom2
Malta1
Cyprus1
Slovakia1
Finland1
Lithuania1
Croatia1
Serbia1
Sweden1
Estonia1
Hungary1

Where are Research Centers of Mirati Therapeutics Patents Located?

R&D Centres of Mirati Therapeutics

10 Best Mirati Therapeutics Patents

WO2005092899A1 is the most popular patent in the Mirati Therapeutics portfolio. It has received 351 citations so far from companies like Merck & Co, Gilead Colorado, Janssen Pharmaceutica.

Below is the list of 10 most cited patents of Mirati Therapeutics:

Publication NumberCitation Count
WO2005092899A1351
WO2008104077A1265
WO2005030704A1252
US6897220B2221
US6541661B1216
WO2004069823A1206
WO2004035525A1196
WO2017201161A1177
WO2008055068A2153
WO2007118137A1145

What Percentage of Mirati Therapeutics US Patent Applications Were Granted?

Mirati Therapeutics (Excluding its subsidiaries) has filed 37 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 22 have been granted leading to a grant rate of 91.67%.

Below are the key stats of Mirati Therapeutics patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Mirati Therapeutics?

Law FirmTotal ApplicationsSuccess Rate
Mirati Wood Phillips17100.00%
Wilson Sonsini Goodrich & Rosati6100.00%
Wood Phillips Katz Clark & Mortimer5100.00%
Fenwick & West Llp450.00%
Mcdonnell Boehnen Hulbert & Berghoff Llp3100.00%
Mbhb Mirati2100.00%

What are Mirati Therapeutics key innovation segments?

What Technologies are Covered by Mirati Therapeutics?

The chart below distributes patents filed by Mirati Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Mirati Therapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Mirati Therapeutics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Mirati Therapeutics?

Related Articles

Alphapharm Patents – Insights & Stats (Updated 2024)

Alphapharm has a total of 108 patents globally, out of which 43 have been granted. Of these 108 patents, more than 18% patents are active. Australia is where Alphapharm has filed the maximum number of patents, followed by Europe (EPO) and United States of America. Parallelly, Australia seems to be

Read More »

Complexa Patents – Insights & Stats (Updated 2024)

Complexa has a total of 77 patents globally, out of which 16 have been granted. Of these 77 patents, more than 22% patents are active. The United States of America is where Complexa has filed the maximum number of patents, followed by Japan. Parallelly, United States of America seems to

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.